z-logo
open-access-imgOpen Access
Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits. Possible mechanisms.
Author(s) -
Kazuhisa Asai,
Chiaki FUNAKI,
Toshio Hayashi,
K. Yamada,
Michitaka Naito,
Masafumi Kuzuya,
Futoshi Yoshida,
Noboru Yoshimine,
Fumio Kuzuya
Publication year - 1993
Publication title -
arteriosclerosis and thrombosis a journal of vascular biology
Language(s) - English
Resource type - Journals
eISSN - 2330-9199
pISSN - 1049-8834
DOI - 10.1161/01.atv.13.6.892
Subject(s) - dexamethasone , endocrinology , medicine , hyperlipidemia , aorta , cholesterol , in vitro , corticosteroid , macrophage , arteriosclerosis , chemistry , biochemistry , diabetes mellitus
We investigated the mechanisms by which corticosteroids affect atherosclerosis. Male New Zealand White rabbits were injected with 0.125 mg dexamethasone (n = 10) or vehicle (control group, n = 10). Both groups were fed a 1% cholesterol diet for 8 weeks. Although the dexamethasone-treated animals exhibited a greater degree of hyperlipidemia, they exhibited significantly less atherosclerotic plaque of the aortic surface than control animals (7.8% versus 47.2%). Immunofluorescence study of the aortic plaque specimens showed that dexamethasone administration reduced both macrophages and T lymphocytes. In vitro, dexamethasone suppressed the proliferation and differentiation of U937 cells and inhibited uptake and degradation of beta-very low density lipoproteins by mouse peritoneal macrophages. These findings suggest that dexamethasone suppresses the development of atherosclerosis in the aorta of rabbits by inhibiting recruitment and proliferation of macrophages and the formation of foam cells in plaques.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom